RTI Surgical Holdings Inc. (RTIX)

4.41
NASDAQ : Health Technology
Prev Close 4.35
Day Low/High 4.31 / 4.43
52 Wk Low/High 3.51 / 6.15
Avg Volume 212.30K
Exchange NASDAQ
Shares Outstanding 73.91M
Market Cap 321.51M
EPS -0.10
P/E Ratio N/A
Div & Yield N.A. (N.A)
RTI Biologics Schedules 2011 Second Quarter Earnings And Conference Call For July 28, 2011

RTI Biologics Schedules 2011 Second Quarter Earnings And Conference Call For July 28, 2011

RTI Biologics Inc. (RTI) (NASDAQ:RTIX), a leading provider of orthopedic and other biologic implants, announced today that it plans to release financial results from the second quarter on Thursday, July 28, 2011 prior...

RTI Biologics Announces Launch Of New Meniscus Allograft Instrumentation

RTI Biologics Announces Launch Of New Meniscus Allograft Instrumentation

RTI Biologics Inc. (RTI) (Nasdaq:RTIX), a leading provider of orthopedic and other biologic implants, announces the launch of new meniscus allograft instrumentation.

RTI Biologics Announces Launch Of BioAdapt™ DBM Foam

RTI Biologics Announces Launch Of BioAdapt™ DBM Foam

RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading provider of orthopedic and other biologic implants, announces the launch of BioAdapt™ DBM Foam, a flexible demineralized bone matrix (DBM) solution with...

RTI Biologics Splits Chairman And CEO Roles

RTI Biologics Splits Chairman And CEO Roles

RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading provider of orthopedic and other biologic implants, announced today that the board of directors has separated the roles of chairman of the board and chief ...

RTI Biologics Announces 2011 First Quarter Results

RTI Biologics Announces 2011 First Quarter Results

RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading provider of orthopedic and other biologic implants, reported operating results for the first quarter of 2011 as follows: Quarterly Highlights: ...

RTI Biologics Schedules 2011 First Quarter Earnings And Conference Call For April 28, 2011

RTI Biologics Schedules 2011 First Quarter Earnings And Conference Call For April 28, 2011

RTI Biologics Inc. (RTI) (Nasdaq:RTIX), a leading provider of orthopedic and other biologic implants, announced today that it plans to release financial results from the first quarter on Thursday, April 28, 2011 prior...

RTI Biologics Announces Processing And Supply Agreement With Alphatec Spine For BioCleanse®-Sterilized Spinal Allografts

RTI Biologics Announces Processing And Supply Agreement With Alphatec Spine For BioCleanse®-Sterilized Spinal Allografts

RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading provider of orthopedic and other biologic implants, announced today that it has signed an agreement to provide spinal allograft implants to Alphatec Spine, Inc.

RTI Biologics Announces 2010 Fourth Quarter, Year End Results

RTI Biologics Announces 2010 Fourth Quarter, Year End Results

RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading provider of orthopedic and other biologic implants, reported operating results for the fourth quarter of 2010 as follows: Quarterly Highlights: ...

RTI Biologics Schedules 2010 Fourth Quarter, Year End Earnings And Conference Call For Feb. 3, 2011

RTI Biologics Schedules 2010 Fourth Quarter, Year End Earnings And Conference Call For Feb. 3, 2011

RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading provider of orthopedic and other biologic implants, announced today that it plans to release financial results from the fourth quarter and year end 2010 on Thursday,...

Insiders Predict These 5 Stocks Will Outperform the Market

Insiders Predict These 5 Stocks Will Outperform the Market

Here are five stocks insiders believe will outperform the S&P 500.

RTI Biologics CEO Discusses Q3 2010 Results - Earnings Call Transcript

RTI Biologics CEO Discusses Q3 2010 Results - Earnings Call Transcript

RTI Biologics Announces 2010 Third Quarter Results

RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading provider of orthopedic and other biologic implants, reported operating results for the third quarter ended Sept.

RTI Biologics Schedules 2010 Third Quarter Earnings And Conference Call For Nov. 4, 2010

RTI Biologics Schedules 2010 Third Quarter Earnings And Conference Call For Nov. 4, 2010

RTI Biologics Inc. (RTI) (Nasdaq:RTIX), a leading provider of orthopedic and other biologic implants, announced today that it plans to release financial results from the third quarter 2010 on Thursday, Nov.

RTI Biologics And Athersys Announce Collaboration In The Orthopedic Market

RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading provider of orthopedic and other biologic implants, and Athersys Inc.

ZymoGenetics, Mitcham: Volume Movers

Several stocks trading below $10, including ZymoGenetics, were poised to move on above-average volume Wednesday.

RTI Biologics And Zimmer Dental Enter Distribution Agreement For Global Dental Biologic Implants

RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading provider of orthopedic and other biologic implants, announced today the signing of an exclusive, 10-year distribution agreement with Zimmer Dental Inc.

RTI Biologics, Medtronic Continue Strong Relationship

RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading processor of orthopedic and other biologic implants, in response to inquiries regarding Medtronic’s announced acquisition of Osteotech stated today that...

RTI Biologics Inc. Q2 2010 Earnings Call Transcript

RTI Biologics Inc. Q2 2010 Earnings Call Transcript

RTI Biologics Announces 2010 Second Quarter Results

RTI Biologics Inc. (RTI) (Nasdaq:RTIX), a leading processor of orthopedic and other biologic implants, reported operating results for the second quarter ended June 30, 2010 as follows: Quarterly...

RTI Biologics Adds Dean H. Bergy To Board Of Directors

RTI Biologics Adds Dean H. Bergy To Board Of Directors

RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading processor of orthopedic and other biologic implants, announced today that Dean H.

RTI Biologics Announces 2010 Second Quarter Earnings And Conference Call

RTI Biologics Inc. (RTI) (Nasdaq:RTIX), a leading processor of orthopedic and other biologic implants, will be releasing financial results from the second quarter on Wednesday, Aug.

Robert P. Jordheim Has Joined RTI Biologics As Executive Vice President And Chief Financial Officer (CFO). (Photo: Business Wire)

RTI Biologics Inc. (RTI) (Nasdaq: RTIX), the Florida-based processor of orthopedic, dental, surgical specialties and other biologic implants, announced organizational and leadership changes today as part of a ...

RTI Biologics, Inc. Q1 2010 Earnings Call Transcript

RTI Biologics, Inc. Q1 2010 Earnings Call Transcript

RTI Biologics Announces 2010 First Quarter Results

RTI Biologics Inc. (RTI) (Nasdaq:RTIX), a leading processor of orthopedic and other biologic implants, reported operating results for the first quarter ending March 31, 2010 as follows: Quarterly Overview: ...

RTI Biologics Announces 2010 First Quarter Earnings And Conference Call

RTI Biologics Inc. (RTI) (Nasdaq:RTIX), a leading processor of orthopedic and other biologic implants, will be releasing financial results from the first quarter on Wednesday, April 28, 2010 before the market opens.

RTI Biologics Launches Reimbursement Hotline For Sports Medicine

RTI Biologics Inc. (RTI) (Nasdaq:RTIX), the Florida-based processor of orthopedic, dental, hernia and other biologic implants, has entered into an agreement with Reimbursement Principles Inc.

RTI Biologics™ Launches Two Biologic Implants At Orthopaedic Surgeon Annual Meeting

RTI Biologics Inc. (RTI) (Nasdaq: RTIX), the Florida-based processor of orthopedic, dental, surgical specialties and other biologic implants, is launching two new biologic implants for use in sports medicine surgeries ...

RTI Biologics Donates Matrix HD™ For Surgeries In Haiti

RTI Biologics Donates Matrix HD™ For Surgeries In Haiti

RTI Biologics Inc. (RTI) (Nasdaq: RTIX), the Florida-based processor of orthopedic, dental, hernia and other biologic implants, has donated Matrix HD™ sterilized dermis allografts to use in limb salvage ...

RTI Biologics' Matrix HD(TM) Terminally Sterlized Dermis Allograft. (Photo: Business Wire)

RTI Biologics Inc. (RTI) (Nasdaq:RTIX), the Florida-based processor of orthopedic, dental, hernia and other biologic implants, has donated a sterilized dermis allograft, Matrix HD ™, to treat an eight-year ...

RTI Biologics 1Q Profit Climbs 60 Percent

RTI says 1st-quarter profit rose following Tutogen acquisition, and specialty sales improved

TheStreet Quant Rating: C (Hold)